CTNNB1 and pituitary tumor: The p.S37C mutation accounts for only 2.8% of all 6939 CTNNB1 mutations analyzed in various mesenchymal and epithelial neoplasms, including hepatocellular, endometrial, ovarian, and pituitary tumors, according to COSMIC (April 2018).